COLLEGIUM PHARMACEUTICAL INC (COLL)
US19459J1043 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 276.9M -10.68% | 463.9M 67.53% | 566.767M 22.17% | 641.56M 13.20% | 754.65M 17.63% | 775.41M 2.75% | 668.26M -13.82% | 666.11M -0.32% | |
| EBITDA YoY % growth | 94M -20.20% | 203.6M 116.60% | 324.717M 59.49% | 404.8M 24.66% | 447.6M 10.57% | 453.54M 1.33% | 374.29M -17.47% | 363.53M -2.87% | |
| EBIT YoY % growth | 25.1M -55.34% | 69.4M 176.49% | 175.461M 152.83% | 181.16M 3.25% | 221.52M 22.28% | 205.23M -7.35% | 284.37M 38.56% | N/A | |
| Operating Margin | 9.06% | 14.96% | 30.96% | 28.24% | 29.35% | 26.47% | 42.55% | N/A | |
| EPS YoY % growth | 0.39 -48.68% | 0.56 43.59% | 1.18 110.71% | 6.29 432.73% | 6.71 6.73% | 7.23 7.74% | 5.88 -18.72% | 7.87 34.03% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.54 87.24% | 1.61 11.33% | 1.67 2.88% | 1.75 8.97% | 1.86 21.24% |
| Revenue Q2Q % growth | 183.07M 22.25% | 184.94M 27.61% | 188.92M 30.04% | 193.99M 21.78% | 199.61M 9.03% |
| EBITDA Q2Q % growth | 105.13M -50.16% | 110.19M 29.78% | 112.52M -4.94% | 115.19M -21.90% | 119.73M 13.89% |
| EBIT Q2Q % growth | 46.74M -24.23% | 61.204M 23.71% | 66.557M 40.21% | 69.645M 99.91% | 71.763M 53.54% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.61 203.77% | 1.62 | -0.01 | -0.88% |
| Q2 2024 Q2Q % growth | 1.62 376.47% | 1.51 | 0.11 | 6.95% |
| Q1 2024 Q2Q % growth | 1.45 384.31% | 0.96 | 0.49 | 51.47% |
| Q4 2023 Q2Q % growth | 0.82 490.48% | 0.67 | 0.15 | 21.81% |
| Q3 2023 Q2Q % growth | 0.53 5,200.00% | 0.53 | 0.00 | 0.57% |
| Q2 2023 Q2Q % growth | 0.34 6.25% | 0.29 | 0.05 | 15.94% |
| Q1 2023 Q2Q % growth | -0.51 -215.91% | 0.32 | -0.83 | -259.24% |
| Q4 2022 Q2Q % growth | -0.21 58.82% | -0.15 | -0.06 | -41.99% |
| Q3 2022 Q2Q % growth | 0.01 -95.45% | -0.14 | 0.15 | 107.26% |
| Q2 2022 Q2Q % growth | 0.32 18.52% | 1.45 | -1.13 | -77.95% |
| Q1 2022 Q2Q % growth | 0.44 7.32% | 0.91 | -0.47 | -51.83% |
| Q4 2021 Q2Q % growth | -0.51 -355.00% | 1.06 | -1.57 | -148.21% |
| Q3 2021 Q2Q % growth | 0.22 -31.25% | 0.97 | -0.75 | -77.34% |
| Q2 2021 Q2Q % growth | 0.27 17.39% | 0.48 | -0.21 | -43.92% |
| Q1 2021 Q2Q % growth | 0.41 4,000.00% | 0.43 | -0.02 | -4.75% |
| Q4 2020 Q2Q % growth | 0.20 385.71% | 0.40 | -0.20 | -49.51% |
| Q3 2020 Q2Q % growth | 0.32 277.78% | 0.42 | -0.10 | -23.21% |
| Q2 2020 Q2Q % growth | 0.23 264.29% | 0.31 | -0.08 | -26.07% |
| Q1 2020 Q2Q % growth | 0.01 103.45% | 0.42 | -0.41 | -97.62% |
| Q4 2019 Q2Q % growth | -0.07 -125.93% | -0.09 | 0.02 | 19.93% |
| Q3 2019 Q2Q % growth | -0.18 64.00% | -0.12 | -0.06 | -48.83% |
| Q2 2019 Q2Q % growth | -0.14 65.00% | -0.18 | 0.04 | 20.60% |
| Q1 2019 Q2Q % growth | -0.29 49.12% | -0.24 | -0.05 | -22.72% |
| Q4 2018 Q2Q % growth | 0.27 | -0.34 | 0.61 | 179.81% |
| Q3 2018 Q2Q % growth | -0.50 | -0.31 | -0.19 | -59.84% |
| Q2 2018 Q2Q % growth | -0.40 | -0.43 | 0.03 | 6.26% |
| Q1 2018 Q2Q % growth | -0.57 | -0.50 | -0.07 | -13.58% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 159.301M 16.52% | 158.69M | 611K | 0.39% |
| Q2 2024 Q2Q % growth | 145.276M 7.18% | 146.82M | -1.544M | -1.05% |
| Q1 2024 Q2Q % growth | 144.923M 0.11% | 149.79M | -4.867M | -3.25% |
| Q4 2023 Q2Q % growth | 149.745M 15.54% | 150.78M | -1.035M | -0.69% |
| Q3 2023 Q2Q % growth | 136.71M 7.65% | 141.03M | -4.32M | -3.06% |
| Q2 2023 Q2Q % growth | 135.546M 9.75% | 141.17M | -5.624M | -3.98% |
| Q1 2023 Q2Q % growth | 144.767M 72.75% | 141.24M | 3.527M | 2.50% |
| Q4 2022 Q2Q % growth | 129.6M 372.99% | 127.7M | 1.9M | 1.49% |
| Q3 2022 Q2Q % growth | 127M 61.17% | 126.82M | 180K | 0.14% |
| Q2 2022 Q2Q % growth | 123.5M 48.97% | 124.09M | -590K | -0.48% |
| Q1 2022 Q2Q % growth | 83.8M -4.45% | 80.461M | 3.339M | 4.15% |
| Q4 2021 Q2Q % growth | 27.4M -64.09% | 83.24M | -55.84M | -67.08% |
| Q3 2021 Q2Q % growth | 78.8M -0.51% | 86.589M | -7.789M | -9.00% |
| Q2 2021 Q2Q % growth | 82.9M 6.15% | 86.468M | -3.568M | -4.13% |
| Q1 2021 Q2Q % growth | 87.7M 14.64% | 83.503M | 4.197M | 5.03% |
| Q4 2020 Q2Q % growth | 76.3M 2.83% | 78.955M | -2.655M | -3.36% |
| Q3 2020 Q2Q % growth | 79.2M 8.64% | 78.977M | 223K | 0.28% |
| Q2 2020 Q2Q % growth | 78.1M 4.13% | 75.893M | 2.207M | 2.91% |
| Q1 2020 Q2Q % growth | 76.5M 2.68% | 78.21M | -1.71M | -2.19% |
| Q4 2019 Q2Q % growth | 74.2M 1.09% | 74.799M | -599K | -0.80% |
| Q3 2019 Q2Q % growth | 72.9M 3.85% | 75.809M | -2.909M | -3.84% |
| Q2 2019 Q2Q % growth | 75M 2.60% | 77.34M | -2.34M | -3.03% |
| Q1 2019 Q2Q % growth | 74.5M 16.95% | 72.233M | 2.267M | 3.14% |
| Q4 2018 Q2Q % growth | 73.4M | 75.334M | -1.934M | -2.57% |
| Q3 2018 Q2Q % growth | 70.2M | 76.284M | -6.084M | -7.98% |
| Q2 2018 Q2Q % growth | 73.1M | 73.648M | -548K | -0.74% |
| Q1 2018 Q2Q % growth | 63.7M | 60.945M | 2.755M | 4.52% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -14.52% | 0.17% | -2% |
| Revenue | 0% | 19.16% | 0.15% | 1.53% |